| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/06/2005 | WO2005000345A2 Immunization method against neisseria meningitidis serogroups a and c |
| 01/06/2005 | WO2005000344A2 Method for identification of tr1 lymphocytes regulators by the presence and overexpression of specific molecules and application thereof |
| 01/06/2005 | WO2005000274A1 Antigen-containing microspheres for the treatment of allergies |
| 01/06/2005 | WO2005000246A2 Methods and compositions for treating rheumatoid arthritis |
| 01/06/2005 | WO2005000244A2 Methods and compositions for treating rheumatoid arthritis |
| 01/06/2005 | WO2005000240A2 Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosis |
| 01/06/2005 | WO2005000239A2 Lyase treatment for p. carinii |
| 01/06/2005 | WO2005000227A2 Methods of treating tnf-mediated disorders |
| 01/06/2005 | WO2005000223A2 Method of treating retinopathies and disorders associated with blood vessel loss |
| 01/06/2005 | WO2005000209A2 An improved method and apparatus for dosing single and multi-agent therapy |
| 01/06/2005 | WO2005000207A2 Pcdgf receptor antibodies and methods of use thereof |
| 01/06/2005 | WO2005000194A2 Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist antibody and compositions containing the same |
| 01/06/2005 | WO2004089417A9 Drug-enclosing multilayer structure particulate and process for producing the same |
| 01/06/2005 | WO2004058167A3 Breast specific protein expressed in cancer and methods of use thereof |
| 01/06/2005 | WO2004053056A3 Nanoparticle-based vaccine delivery system containing adjuvant |
| 01/06/2005 | WO2004041997A3 Immunotherapy regimens in hiv-infected patients |
| 01/06/2005 | WO2003102165A3 IMMUNOGENIC HBc CHIMER PARTICLES STABILIZED WITH AN N-TERMINAL CYSTEINE |
| 01/06/2005 | WO2003097688A9 Muteins of placental growth factor type 1, preparation method and application thereof |
| 01/06/2005 | WO2003050255A3 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer |
| 01/06/2005 | WO2003032907A9 High-concentration protein formulations and method of manufacture |
| 01/06/2005 | WO2002096923A9 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes |
| 01/06/2005 | US20050005312 Propagation of human hepatocytes in non-human animals |
| 01/06/2005 | US20050004510 Noninvasive vascular therapy |
| 01/06/2005 | US20050004352 Single-chain multiple antigen-binding molecule, its preparation and use |
| 01/06/2005 | US20050004351 Therapeutic and diagnostic domain 1 beta2GP1 polypeptides and methods of using same |
| 01/06/2005 | US20050004349 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 01/06/2005 | US20050004346 Recombinant anti-plasmodium falciparum antibodies |
| 01/06/2005 | US20050004063 nucleotide sequence which was designed based on portions of the genomic sequences of the different strains of the hSARS virus and their use as therapeutic agents in therapeutic methods |
| 01/06/2005 | US20050004062 Immunostimulatory oligonucleotides; activation lymphocytes; antibody therapy; anticancer agents |
| 01/06/2005 | US20050004061 Immunostimulatory nucleic acid molecules |
| 01/06/2005 | US20050004056 Ptp10d, tec protein tyrosine kinase and edtp homologous proteins involved in the regulation of energy homeostasis |
| 01/06/2005 | US20050004054 Polyvalent vaccine against diseases caused by papilloma viruses, method for the production and the use thereof |
| 01/06/2005 | US20050004040 Peptide having an affinity for gp120 |
| 01/06/2005 | US20050004020 Anchoring compound to surface of target cells; protease inhibitors |
| 01/06/2005 | US20050004001 Diagnosis, prevention, therapy of autoimmune diseases, antiallergens, anticancer agents, antidiabetic agents |
| 01/06/2005 | US20050003549 Nucleotide sequences coding methyltransferase for use in identifying modulators for treatment of respiratory disorders in cattle; veterinary medicine |
| 01/06/2005 | US20050003539 Plasmid maintenance system for antigen delivery |
| 01/06/2005 | US20050003512 Attenuated pasteurella for use as tool in developing bactericidal agents; immunotherapy |
| 01/06/2005 | US20050003493 Kit comprising immunoblobulins which bind the bioactive, three-dimensional epitope of parathyroid hormone for use in classifying hypercalcemic disorders |
| 01/06/2005 | US20050003492 Novel polypeptide |
| 01/06/2005 | US20050003490 Immunoglobulins specific for cell surface protein for use in diagnosis, prevention and treatment of cell proliferative disorders; inhibitory action associated with reduced cellular transport of amino acids |
| 01/06/2005 | US20050003489 Conformational and topological protein regulation |
| 01/06/2005 | US20050003484 Modified antigen-presenting cells |
| 01/06/2005 | US20050003483 Major histocompatibility complex peptide ligand for use in identifying modulators which prevent transplantation and autoimmunity disorders; immunotherapy |
| 01/06/2005 | US20050003465 Monoclonal abtibody specific to prostate cell-surface antigen associated with androgen-dependent and androgen-independent prostate tumors for use in prevention, diagnosis and treatment of cell proliferative disorders; immunodiagnostics; immunotherapy |
| 01/06/2005 | US20050003457 Immunoglobulin which binds osteoclastogenesis inhibitory factor binding molecules (OBM)) and prevents bone resorption for use in treatment and prevention of bone disorders |
| 01/06/2005 | US20050003454 Conformational and topological protein regulation |
| 01/06/2005 | US20050003451 Immunoglobulin for use in diagnosis, prevention and treatment of infection, autoimmune, inflammatory and cell proliferative diseases; immunotherapy |
| 01/06/2005 | US20050003448 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 01/06/2005 | US20050003438 Conformational and topological protein regulation |
| 01/06/2005 | US20050003433 Recombinant neospora antigens and their uses |
| 01/06/2005 | US20050003425 Nucleotide sequences coding tumor marker protein for use in diagnosis and/or prognosis of cell proliferative disorders |
| 01/06/2005 | US20050003403 Multimeric protien for use in treatment and prevention of infections, nervous system, inflammatory, autoimmune and cell proliferative disorders |
| 01/06/2005 | US20050003400 Using osteoprotegrin binding agent as tool in identifying modulator for treatment and prevention of osteoporosis and bone disorders |
| 01/06/2005 | US20050003397 Peptide useful in immunomodulation |
| 01/06/2005 | US20050003391 Bioassay for detection of receptor activated nuclear factor kappa beta ligand (RANKL); identifying modulator immune and inflammatory response |
| 01/06/2005 | US20050003370 Expression vector comprising nucleotide sequences coding membrane receptor proteins for use in identifying modulators for treatment and prevention of cell proliferative, nervous system, reproductive cardiovascular and inflammation disorders |
| 01/06/2005 | US20050003368 Cancer monitoring and therapeutics |
| 01/06/2005 | US20050003345 Synthetic antigens for the detection of antibodies to hepatitis C virus |
| 01/06/2005 | US20050002969 Binary composition for prime-boost release of active ingredients like vaccines |
| 01/06/2005 | US20050002967 Kit comprised of at least three different immunogenic compositions |
| 01/06/2005 | US20050002966 Attenuated pestiviruses |
| 01/06/2005 | US20050002960 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 01/06/2005 | US20050002958 Vaccines |
| 01/06/2005 | US20050002957 Long lasting immunity to variety of Neisseria meningitidis strains |
| 01/06/2005 | US20050002956 Vaccine |
| 01/06/2005 | US20050002955 Acquired Immune Deficiency Syndrome (AIDS) diagnosis and treatment |
| 01/06/2005 | US20050002954 Peptide-based vaccine for influenza |
| 01/06/2005 | US20050002953 Recombinant vectors expressing E, M and/or S proteins; cell line |
| 01/06/2005 | US20050002952 Proteinaceous antigen with 3-beta-(N-(N'-N'-dimethylaminoethane)carbamoyl)cholesterol; increasing immunogenicity |
| 01/06/2005 | US20050002951 Novel method of inducing antigen-specific t cells |
| 01/06/2005 | US20050002950 Vaccine preventing infection |
| 01/06/2005 | US20050002949 Prevention and treatment of irritable bowel syndrome |
| 01/06/2005 | US20050002948 Method of enhanced immunogenicity to meningococcal vaccination |
| 01/06/2005 | US20050002947 Screening candidate anthelmintic materials for immobilization and toxicity activity |
| 01/06/2005 | US20050002946 Vaccines and agents for inducing immunity in fish against rickettsial diseases, and associated preventative therapy |
| 01/06/2005 | US20050002944 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 01/06/2005 | US20050002943 Amp-kinase agonists or adenosine pro-drugs as immuno-stimulating agents |
| 01/06/2005 | US20050002942 Vitamin receptor binding drug delivery conjugates |
| 01/06/2005 | US20050002941 antibody, immunoconjugate and duramycin-based compositions; bind and inhibit anionic phospholipids and aminophospholipids, for use in the safe and effective treatment of cancer, viral infections and related diseases |
| 01/06/2005 | US20050002939 Treating ovarian cancer |
| 01/06/2005 | US20050002938 To screen for inhibitors of cell growth and to develop small molecule therapeutics for treating cancers |
| 01/06/2005 | US20050002937 Anti-IL-12 antibodies, compositions, methods and uses |
| 01/06/2005 | US20050002936 Methods and compositions useful for inhibition of angiogenesis |
| 01/06/2005 | US20050002934 Recombinant IL-9 antibodies and uses thereof |
| 01/06/2005 | US20050002932 Alleviation of symptoms associated with inflammatory disease states |
| 01/06/2005 | US20050002929 Using NK gene complex family of type II oligomeric signal transmitting receptor proteins containing C-type lectin-binding domain; increasing tumor necrosis factor alpha production; autoimmune diseases |
| 01/06/2005 | US20050002928 Treatment with anti-ErbB2 antibodies |
| 01/06/2005 | US20050002925 Surface proteins from gram-positive bacteria having highly conserved motifs and antibodies that recognize them |
| 01/06/2005 | US20050002920 Collecting, activating, culturing and optionally expanding peripheral blood mononuclear cells then hypomethylating with 5-aza-cytidine or 5-aza-2'-deoxycytidine |
| 01/06/2005 | US20050002916 Cytokine-expressing cellular vaccine combinations |
| 01/06/2005 | US20050002901 Compositions and methods for treating coronavirus infection and SARS |
| 01/06/2005 | US20050002900 Inhibiting estradiol production in human adipocytes using interferon gamma and/or tumor necrosis factor antagonist and/or interleukin-1 antagonist; reducing side effects |
| 01/06/2005 | US20050002867 Buccal, polar and non-polar sprays containing propofol |
| 01/06/2005 | CA2530582A1 Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosis |
| 01/06/2005 | CA2530434A1 Immunization method against neisseria meningitidis serogroups a and c |
| 01/06/2005 | CA2530388A1 Modified binding molecules comprising connecting peptides |
| 01/06/2005 | CA2530386A1 Antibodies against interleukin-22 and uses therefor |
| 01/06/2005 | CA2530364A1 Vaccines against group y neisseria meningitidis and meningococcal combinations thereof |
| 01/06/2005 | CA2530363A1 Carrier proteins for vaccines |